Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy.

While Alphabet's addition to the Dow and prominence in Berkshire Hathaway's portfolio has garnered significant attention, Prestige Consumer Healthcare may offer better investment potential. Prestige completed its largest acquisition, purchasing Breathe Right and other OTC brands for $1.045 billion, expanding its portfolio of category-leading brands. The company is also positioning itself to benefit from GLP-1 weight-loss medication side effects through its existing brands like Dramamine and Fleet. However, the acquisition has elevated debt to 4.0x EBITDA, requiring successful execution to reduce leverage by 2028.